CAMP
CAMP4 TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CAMP Profile
Camp4 Therapeutics Corporation
A biopharmaceutical company that uses RNA based regulatory therapy to treat various genetic diseases in clinical stages
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, Massachusetts 02139
--
CAMP4 Therapeutics Corporation was originally incorporated in Delaware in 2015 and began operations in 2016. They are a clinical-stage biopharmaceutical company that has pioneered the discovery and development of RNA-based regulatory therapies designed to up-regulate gene expression and restore healthy protein levels for the treatment of various genetic diseases. Regulatory RNAs, or regRNAs, play a central role in the regulation of each protein-coding gene by promoting gene activation and suppression. Their method aims to amplify the expression of messenger RNA or mRNA by harnessing the power of regRNAs, which form local complexes with transcription factors and regulate gene expression. Their proprietary RNA drive platform, or RAP platform, enables them to rapidly and systematically identify and characterize the active regulatory elements that control each expressed gene and the tens of thousands of druggable enhancers and promoter regRNA sequences that control protein-coding genes.
